{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:23:01Z","timestamp":1767774181407,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1011301","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Amsterdam Data Science"},{"DOI":"10.13039\/501100002203","name":"Brain Tumour Charity","doi-asserted-by":"publisher","award":["488097"],"award-info":[{"award-number":["488097"]}],"id":[{"id":"10.13039\/501100002203","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Exchange Amsterdam (IXA) grant","award":["APCAPoC- 2017"],"award-info":[{"award-number":["APCAPoC- 2017"]}]},{"DOI":"10.13039\/100019573","name":"Amsterdam University Medical Centers","doi-asserted-by":"publisher","award":["GlioSPARK project 2018-2-19"],"award-info":[{"award-number":["GlioSPARK project 2018-2-19"]}],"id":[{"id":"10.13039\/100019573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Many therapies in clinical trials are based on single drug-single target relationships. To further extend this concept to multi-target approaches using multi-targeted drugs, we developed a machine learning pipeline to unravel the target landscape of kinase inhibitors. This pipeline, which we call 3D-KINEssence, uses a new type of protein fingerprints (3D FP) based on the structure of kinases generated through a 3D convolutional neural network (3D-CNN). These 3D-CNN kinase fingerprints were matched to molecular Morgan fingerprints to predict the targets of each respective kinase inhibitor based on available bioactivity data. The performance of the pipeline was evaluated on two test sets: a sparse drug-target set where each drug is matched in most cases to a single target and also on a densely-covered drug-target set where each drug is matched to most if not all targets. This latter set is more challenging to train, given its non-exclusive character. Our model\u2019s root-mean-square error (RMSE) based on the two datasets was 0.68 and 0.8, respectively. These results indicate that 3D FP can predict the target landscape of kinase inhibitors at around 0.8 log units of bioactivity. Our strategy can be utilized in proteochemometric or chemogenomic workflows by consolidating the target landscape of kinase inhibitors.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1011301","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:31:12Z","timestamp":1693920672000},"page":"e1011301","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks"],"prefix":"10.1371","volume":"19","author":[{"given":"Georgi K.","family":"Kanev","sequence":"first","affiliation":[]},{"given":"Yaran","family":"Zhang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-6021","authenticated-orcid":true,"given":"Albert J.","family":"Kooistra","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Bender","sequence":"additional","affiliation":[]},{"given":"Rob","family":"Leurs","sequence":"additional","affiliation":[]},{"given":"David","family":"Bailey","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"W\u00fcrdinger","sequence":"additional","affiliation":[]},{"given":"Chris","family":"de Graaf","sequence":"additional","affiliation":[]},{"given":"Iwan J. P.","family":"de Esch","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9898-9616","authenticated-orcid":true,"given":"Bart A.","family":"Westerman","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"pcbi.1011301.ref001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/9781118681121.ch3","article-title":"Structural Chemogenomics: Profiling Protein\u2013Ligand Interactions in Polypharmacological Space.","author":"B Briels","year":"2020","journal-title":"Structural Biology in Drug Discovery: Methods, Techniques, and Practices."},{"key":"pcbi.1011301.ref002","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial","author":"MJ Pishvaian","year":"2020","journal-title":"The Lancet Oncology"},{"issue":"7776","key":"pcbi.1011301.ref003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1600-x","article-title":"The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs","volume":"574","author":"D Van der Velden","year":"2019","journal-title":"Nature"},{"issue":"5","key":"pcbi.1011301.ref004","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ccell.2018.03.025","article-title":"A convergence-based framework for cancer drug resistance","volume":"33","author":"DJ Konieczkowski","year":"2018","journal-title":"Cancer Cell"},{"key":"pcbi.1011301.ref005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drup.2019.04.002","article-title":"The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation","volume":"43","author":"H Saleem","year":"2019","journal-title":"Drug Resist Updat"},{"issue":"1","key":"pcbi.1011301.ref006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"RW Jenkins","year":"2018","journal-title":"Br J Cancer"},{"issue":"5","key":"pcbi.1011301.ref007","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/acs.jcim.8b00832","article-title":"Advances and Challenges in Computational Target Prediction.","volume":"59","author":"D Sydow","year":"2019","journal-title":"J Chem Inf Model."},{"issue":"1","key":"pcbi.1011301.ref008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C0MD00165A","article-title":"Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets","volume":"2","author":"GJP van Westen","year":"2011","journal-title":"Med Chem Commun"},{"issue":"1","key":"pcbi.1011301.ref009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/C4MD00216D","article-title":"Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects.","volume":"6","author":"I Cort\u00e9s-Ciriano","year":"2015","journal-title":"Med Chem Commun"},{"issue":"11","key":"pcbi.1011301.ref010","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"AL Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"issue":"1","key":"pcbi.1011301.ref011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"AL Barabasi","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"3","key":"pcbi.1011301.ref012","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.chembiol.2018.11.005","article-title":"What Makes a Kinase Promiscuous for Inhibitors","volume":"26","author":"SM Hanson","year":"2019","journal-title":"Cell Chem Biol"},{"key":"pcbi.1011301.ref013","first-page":"358","article-title":"The target landscape of clinical kinase drugs","author":"S Klaeger","year":"2017","journal-title":"Science"},{"issue":"3","key":"pcbi.1011301.ref014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"MA Fabian","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"11","key":"pcbi.1011301.ref015","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"MI Davis","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"11","key":"pcbi.1011301.ref016","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"T Anastassiadis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"pcbi.1011301.ref017","article-title":"Comprehensive characterization of the Published Kinase Inhibitor Set","author":"JM Elkins","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"46","key":"pcbi.1011301.ref018","doi-asserted-by":"crossref","first-page":"15774","DOI":"10.1021\/jacs.8b08048","article-title":"Binding Kinetics Survey of the Drugged Kinome","volume":"140","author":"V Georgi","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"9\u201310","key":"pcbi.1011301.ref019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery.","volume":"18","author":"JL Medina-Franco","year":"2013","journal-title":"Drug Discov Today."},{"key":"pcbi.1011301.ref020","doi-asserted-by":"crossref","first-page":"106552","DOI":"10.1016\/j.phrs.2022.106552","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update","volume":"187","author":"R. Roskoski","year":"2023","journal-title":"Pharmacol Res"},{"key":"pcbi.1011301.ref021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"R Roskoski","year":"2019","journal-title":"Pharmacol Res"},{"issue":"11","key":"pcbi.1011301.ref022","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tips.2019.09.002","article-title":"The Landscape of Atypical and Eukaryotic Protein Kinases","volume":"40","author":"GK Kanev","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"5726","key":"pcbi.1011301.ref023","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1126\/science.1113707","article-title":"Lessons in Rational Drug Design for Protein Kinases","volume":"308","author":"NG Ahn","year":"2005","journal-title":"Science"},{"issue":"2","key":"pcbi.1011301.ref024","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/0008-5472.CAN-16-0097","article-title":"Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer","volume":"77","author":"S Jaeger","year":"2017","journal-title":"Cancer Res"},{"key":"pcbi.1011301.ref025","article-title":"Polypharmacology by Design: A Medicinal Chemist\u2019s Perspective on Multitargeting Compounds","author":"E Proschak","year":"2018","journal-title":"J Med Chem"},{"issue":"6","key":"pcbi.1011301.ref026","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"MC Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"509","key":"pcbi.1011301.ref027","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"A Lin","year":"2019","journal-title":"Sci Transl Med"},{"issue":"7019","key":"pcbi.1011301.ref028","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries","volume":"432","author":"BK Shoichet","year":"2004","journal-title":"Nature"},{"issue":"8","key":"pcbi.1011301.ref029","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/17460441.3.8.841","article-title":"What has virtual screening ever done for drug discovery?","volume":"3","author":"DE Clark","year":"2008","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"pcbi.1011301.ref030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd3139","article-title":"Virtual screening: an endless staircase?","volume":"9","author":"G. Schneider","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"pcbi.1011301.ref031","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/ci200528d","article-title":"Recognizing pitfalls in virtual screening: a critical review.","volume":"52","author":"T Scior","year":"2012","journal-title":"J Chem Inf Model"},{"issue":"4","key":"pcbi.1011301.ref032","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138620709788167980","article-title":"Machine learning in virtual screening.","volume":"12","author":"JL Melville","year":"2009","journal-title":"Combinatorial Chem High Throughput Screening"},{"issue":"1","key":"pcbi.1011301.ref033","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","article-title":"In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling","volume":"152","author":"S Ekins","year":"2007","journal-title":"Br J Pharmacol"},{"key":"pcbi.1011301.ref034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.sbi.2018.01.006","article-title":"Statistical and machine learning approaches to predicting protein-ligand interactions","volume":"49","author":"LJ Colwell","year":"2018","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"pcbi.1011301.ref035","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s41467-021-23165-1","article-title":"Crowdsourced mapping of unexplored target space of kinase inhibitors","volume":"12","author":"A Cicho\u0144ska","year":"2021","journal-title":"Nature Communications"},{"issue":"6","key":"pcbi.1011301.ref036","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling","volume":"43","author":"V Svetnik","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"issue":"9","key":"pcbi.1011301.ref037","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/bioinformatics\/btq112","article-title":"A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking","volume":"26","author":"PJ Ballester","year":"2010","journal-title":"Bioinformatics"},{"key":"pcbi.1011301.ref038","article-title":"Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?","author":"S Christmann-Franck","year":"2016","journal-title":"J Chem Inf Model."},{"issue":"1","key":"pcbi.1011301.ref039","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/acs.jmedchem.6b01611","article-title":"Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay","volume":"60","author":"B Merget","year":"2017","journal-title":"J Med Chem"},{"issue":"3","key":"pcbi.1011301.ref040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/138620706776055539","article-title":"Computational Methods in Developing Quantitative Structure-Activity Relationships (QSAR): A Review.","volume":"9","author":"ZD Arkadiusz","year":"2006","journal-title":"Combinatorial Chem High Throughput Screening."},{"issue":"2","key":"pcbi.1011301.ref041","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/ci100369f","article-title":"A machine learning-based method to improve docking scoring functions and its application to drug repurposing.","volume":"51","author":"SL Kinnings","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pcbi.1011301.ref042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ps.2780360212","article-title":"The Use of Artificial Neural Networks in QSAR","volume":"36","author":"DW Salt","year":"1992","journal-title":"Pestic Sci"},{"issue":"10","key":"pcbi.1011301.ref043","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/ci100244v","article-title":"NNScore: A Neural-Network-Based Scoring Function for the Characterization of Protein\u2212Ligand Complexes.","volume":"50","author":"JD Durrant","year":"2010","journal-title":"J Chem Inf Model."},{"issue":"7","key":"pcbi.1011301.ref044","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","article-title":"Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data","volume":"13","author":"A Aliper","year":"2016","journal-title":"Mol Pharm"},{"issue":"1","key":"pcbi.1011301.ref045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13321-017-0232-0","article-title":"Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.","volume":"9","author":"EB Lenselink","year":"2017","journal-title":"J Cheminform."},{"issue":"7553","key":"pcbi.1011301.ref046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning.","volume":"521","author":"Y LeCun","year":"2015","journal-title":"Nature"},{"issue":"12","key":"pcbi.1011301.ref047","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/acs.jcim.6b00355","article-title":"Boosting Docking-Based Virtual Screening with Deep Learning.","volume":"56","author":"JC Pereira","year":"2016","journal-title":"J Chem Inf Model."},{"key":"pcbi.1011301.ref048","article-title":"Massively multitask networks for drug discovery.","author":"B Ramsundar","year":"2015","journal-title":"arXiv preprint arXiv:150202072."},{"key":"pcbi.1011301.ref049","first-page":"23","article-title":"Artificial Intelligence in Drug Design. Molecules","author":"G Hessler","year":"2018"},{"key":"pcbi.1011301.ref050","first-page":"1","article-title":"An overview of neural networks for drug discovery and the inputs used.","author":"Y Xu","year":"2018","journal-title":"Expert Opin Drug Discov."},{"issue":"8","key":"pcbi.1011301.ref051","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1109\/TPAMI.2013.50","article-title":"Representation learning: A review and new perspectives","volume":"35","author":"Y Bengio","year":"2013","journal-title":"IEEE transactions on pattern analysis and machine intelligence"},{"issue":"1","key":"pcbi.1011301.ref052","first-page":"1929","article-title":"Dropout: a simple way to prevent neural networks from overfitting","volume":"15","author":"N Srivastava","year":"2014","journal-title":"The Journal of Machine Learning Research"},{"issue":"6","key":"pcbi.1011301.ref053","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery.","volume":"23","author":"H Chen","year":"2018","journal-title":"Drug Discov Today."},{"issue":"4","key":"pcbi.1011301.ref054","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1162\/neco.1989.1.4.541","article-title":"Backpropagation applied to handwritten zip code recognition.","volume":"1","author":"Y LeCun","year":"1989","journal-title":"Neural Comput"},{"issue":"11","key":"pcbi.1011301.ref055","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1109\/5.726791","article-title":"Gradient-based learning applied to document recognition","volume":"86","author":"Y LeCun","year":"1998","journal-title":"Proc IEEE"},{"issue":"21","key":"pcbi.1011301.ref056","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/bioinformatics\/bty374","article-title":"Development and evaluation of a deep learning model for protein-ligand binding affinity prediction","volume":"34","author":"MM Stepniewska-Dziubinska","year":"2018","journal-title":"Bioinformatics"},{"key":"pcbi.1011301.ref057","article-title":"AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery.","author":"I Wallach","year":"2015","journal-title":"arXiv preprint arXiv:151002855."},{"issue":"2","key":"pcbi.1011301.ref058","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.jcim.7b00650","article-title":"K DEEP: Protein\u2013Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks.","volume":"58","author":"J Jim\u00e9nez","year":"2018","journal-title":"J Chem Inf Model."},{"key":"pcbi.1011301.ref059","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.compbiomed.2017.09.007","article-title":"Interaction prediction in structure-based virtual screening using deep learning","volume":"100","author":"A Gonczarek","year":"2018","journal-title":"Comput Biol Med"},{"key":"pcbi.1011301.ref060","article-title":"Chemception: A deep neural network with minimal chemistry knowledge matches the performance of expert-developed qsar\/qspr models.","author":"GB Goh","year":"2017","journal-title":"arXiv preprint arXiv:170606689."},{"issue":"17","key":"pcbi.1011301.ref061","doi-asserted-by":"crossref","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","article-title":"DeepDTA: deep drug-target binding affinity prediction","volume":"34","author":"H Ozturk","year":"2018","journal-title":"Bioinformatics"},{"key":"pcbi.1011301.ref062","article-title":"Atomic convolutional networks for predicting protein-ligand binding affinity.","author":"J Gomes","year":"2017","journal-title":"arXiv preprint arXiv:170310603."},{"issue":"7","key":"pcbi.1011301.ref063","doi-asserted-by":"crossref","first-page":"e1005690","DOI":"10.1371\/journal.pcbi.1005690","article-title":"TopologyNet: Topology based deep convolutional and multi-task neural networks for biomolecular property predictions.","volume":"13","author":"Z Cang","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"18","key":"pcbi.1011301.ref064","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/bioinformatics\/btz111","article-title":"DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks","volume":"35","author":"M Karimi","year":"2019","journal-title":"Bioinformatics"},{"key":"pcbi.1011301.ref065","volume-title":"Convolutional networks on graphs for learning molecular fingerprints","author":"DK Duvenaud","year":"2015"},{"issue":"10","key":"pcbi.1011301.ref066","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/acs.molpharmaceut.7b01134","article-title":"3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks","volume":"15","author":"D Kuzminykh","year":"2018","journal-title":"Mol Pharm"},{"issue":"19","key":"pcbi.1011301.ref067","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12859-018-2523-5","article-title":"Convolutional neural network based on SMILES representation of compounds for detecting chemical motif","volume":"19","author":"M Hirohara","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"pcbi.1011301.ref068","doi-asserted-by":"crossref","DOI":"10.1145\/3219819.3219838","volume-title":"Using Rule-Based Labels for Weak Supervised Learning: A ChemNet for Transferable Chemical Property Prediction","author":"GB Goh","year":"2018"},{"issue":"4","key":"pcbi.1011301.ref069","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acs.jcim.6b00740","article-title":"Protein-Ligand Scoring with Convolutional Neural Networks.","volume":"57","author":"M Ragoza","year":"2017","journal-title":"J Chem Inf Model."},{"key":"pcbi.1011301.ref070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jmgm.2018.06.005","article-title":"Visualizing convolutional neural network protein-ligand scoring","volume":"84","author":"J Hochuli","year":"2018","journal-title":"J Mol Graph Model"},{"issue":"12","key":"pcbi.1011301.ref071","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/jm030580l","article-title":"The PDBbind database: Collection of binding affinities for protein\u2212 ligand complexes with known three-dimensional structures","volume":"47","author":"R Wang","year":"2004","journal-title":"J Med Chem"},{"issue":"3","key":"pcbi.1011301.ref072","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/acs.jcim.9b01145","article-title":"libmolgrid: Graphics Processing Unit Accelerated Molecular Gridding for Deep Learning Applications.","volume":"60","author":"J Sunseri","year":"2020","journal-title":"J Chem Inf Model."},{"issue":"D1","key":"pcbi.1011301.ref073","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"D Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"pcbi.1011301.ref074","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ci990307l","article-title":"Prediction of physicochemical parameters by atomic contributions","volume":"39","author":"SA Wildman","year":"1999","journal-title":"J Chem Inf Comput Sci"},{"key":"pcbi.1011301.ref075","first-page":"D365","article-title":"KLIFS: a structural kinase-ligand interaction database","author":"AJ Kooistra","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1011301.ref076","doi-asserted-by":"crossref","first-page":"D562","DOI":"10.1093\/nar\/gkaa895","article-title":"KLIFS: an overhaul after the first 5 years of supporting kinase research","volume":"49","author":"GK Kanev","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1011301.ref077","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1145\/1656274.1656280","article-title":"KNIME\u2014the Konstanz information miner: version 2.0 and beyond.","volume":"11","author":"MR Berthold","year":"2009","journal-title":"SIGKDD Explor Newsl"},{"issue":"1","key":"pcbi.1011301.ref078","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-4165(00)00187-2","article-title":"Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions","volume":"1525","author":"M Lapinsh","year":"2001","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014General Subjects."},{"issue":"11","key":"pcbi.1011301.ref079","doi-asserted-by":"crossref","first-page":"e0141287","DOI":"10.1371\/journal.pone.0141287","article-title":"Continuous Distributed Representation of Biological Sequences for Deep Proteomics and Genomics.","volume":"10","author":"E Asgari","year":"2015","journal-title":"PLoS One"},{"key":"pcbi.1011301.ref080","author":"G. Landrum","year":"2006","journal-title":"RDKit: Open-source cheminformatics"},{"issue":"1","key":"pcbi.1011301.ref081","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules","volume":"28","author":"D. Weininger","year":"1988","journal-title":"J Chem Inf Comput Sci"},{"issue":"3","key":"pcbi.1011301.ref082","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cbpa.2008.01.044","article-title":"Computational analysis of ligand relationships within target families","volume":"12","author":"J. Bajorath","year":"2008","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"pcbi.1011301.ref083","first-page":"57","article-title":"Computational chemogenomics.","volume":"1","author":"E. Jacoby","year":"2011","journal-title":"Wiley Interdisciplinary Reviews: Computational Molecular Science."},{"issue":"7873","key":"pcbi.1011301.ref084","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J Jumper","year":"2021","journal-title":"Nature"},{"issue":"Database issue","key":"pcbi.1011301.ref085","first-page":"D204","article-title":"UniProt: a hub for protein information","volume":"43","author":"C. UniProt","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1011301.ref086","first-page":"44","article-title":"Peptides: A package for data mining of antimicrobial peptides","volume":"12","author":"D Osorio","year":"2015","journal-title":"Small"},{"key":"pcbi.1011301.ref087","article-title":"Pytorch: An imperative style, high-performance deep learning library.","volume":"32","author":"A Paszke","year":"2019","journal-title":"Adv Neural Inf Process Syst"},{"issue":"5\u20136","key":"pcbi.1011301.ref088","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/minf.201200133","article-title":"Ambit-Tautomer: An Open Source Tool for Tautomer Generation.","volume":"32","author":"NT Kochev","year":"2013","journal-title":"Mol Inform."},{"key":"pcbi.1011301.ref089","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","journal-title":"Scikit-learn: Machine learning in Python. the Journal of machine Learning research."}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1011301","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1011301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:32:54Z","timestamp":1695130374000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1011301"}},"subtitle":[],"editor":[{"given":"Francesca","family":"Fanelli","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":89,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1011301","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}